Gilead Sciences

Gilead Sciences Photos

Gilead Alberta ULC

+ Add Photo

Gilead Sciences Reviews

200 Reviews
200 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Gilead Sciences Chairman & CEO John C. Martin
John C. Martin
113 Ratings

Gilead Sciences Interviews

Updated Dec 20, 2014
Updated Dec 20, 2014

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Security Manager Interview

    Anonymous Employee in Foster City, CA
    Anonymous Employee in Foster City, CA
    Application Details

    I applied through other source. The process took 3+ monthsinterviewed at Gilead Sciences.

    Interview Details

    I was temp worker at the time position opened. I submitted an online application. After couple of days staffing consultant contacted me to schedule a face to face interview. 7 people interviewed.some of them 1:1 and couple of them are panel.

    Interview Questions
    No Offer
    Negative Experience
    Average Interview

Gilead Sciences Awards & Accolades

Something missing? Add an award
100 Fastest Growing Companies, Fortune, 2009
America's Top Companies, Forbes, 2009
Show More

Additional Info

Unlock Profile
Headquarters Foster City, CA
Size 5000+ Employees
Founded 1987
Type Company - Public (GILD)
Industry Biotech & Pharmaceuticals
Revenue $10+ billion (USD) per year

Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes Truvada, a combination of two of its other drugs, Viread and Emtriva. It co-promotes another HIV treatment, called Atripla, in the US and Europe with Bristol-Myers Squibb. Other products on the market include AmBisome, used to treat systemic fungal infections such as those that accompany AIDS; Vistide, for AIDS-related eye infections; and hepatitis B antiviral Hepsera. Beyond HIV/AIDS, Gilead also markets Letairis, a... More

Work at Gilead Sciences? Share Your Experiences

Gilead Sciences

Click to Rate